Sale!

CD2AP Gene Focal Segmental Glomerulosclerosis Type 3 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The CD2AP Gene Focal Segmental Glomerulosclerosis Type 3 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the CD2AP gene associated with inherited kidney disorders. This comprehensive test utilizes Next-Generation Sequencing technology to detect genetic variations that cause focal segmental glomerulosclerosis, a serious kidney condition affecting glomerular filtration. Patients experiencing unexplained proteinuria, hematuria, or progressive kidney dysfunction should consider this test for accurate diagnosis and personalized treatment planning. The test provides crucial information for family planning and early intervention strategies. Results are typically available within 3-4 weeks from blood or DNA samples. This essential genetic screening is available for only $500 USD, offering significant savings from the regular $700 price.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

CD2AP Gene Focal Segmental Glomerulosclerosis Type 3 NGS Genetic DNA Test

Comprehensive Genetic Testing for Inherited Kidney Disorders

The CD2AP Gene Focal Segmental Glomerulosclerosis Type 3 NGS Genetic DNA Test represents a breakthrough in precision medicine for kidney health. This advanced diagnostic tool specifically targets mutations in the CD2AP (CD2-associated protein) gene, which plays a critical role in maintaining the structural integrity of kidney glomeruli. When this gene malfunctions, it can lead to focal segmental glomerulosclerosis (FSGS), a serious condition characterized by scarring of kidney tissue that progressively impairs filtration function.

What This Revolutionary Test Detects

Our comprehensive NGS-based analysis examines the complete CD2AP gene sequence to identify:

  • Pathogenic variants and mutations in the CD2AP gene
  • Single nucleotide polymorphisms associated with FSGS Type 3
  • Deletion and insertion mutations affecting protein function
  • Genetic markers indicating inherited kidney disease susceptibility
  • Variants that disrupt the slit diaphragm complex in glomeruli

Who Should Consider CD2AP Genetic Testing?

This test is particularly recommended for individuals experiencing:

  • Unexplained proteinuria or albuminuria
  • Persistent hematuria without clear cause
  • Progressive kidney dysfunction in young adults
  • Family history of FSGS or inherited kidney disease
  • Resistant hypertension with renal involvement
  • Edema and fluid retention suggesting nephrotic syndrome
  • Children with steroid-resistant nephrotic syndrome
  • Patients requiring kidney transplant evaluation

Significant Benefits of Early Genetic Detection

Undergoing CD2AP genetic testing provides numerous advantages for comprehensive healthcare management:

  • Precise Diagnosis: Differentiates genetic FSGS from other kidney conditions
  • Personalized Treatment: Enables targeted therapeutic approaches
  • Family Planning Guidance: Informs reproductive decisions and genetic counseling
  • Early Intervention: Facilitates proactive management before significant kidney damage occurs
  • Risk Assessment: Identifies at-risk family members for preventive monitoring
  • Transplant Planning: Guides living donor selection and post-transplant care

Understanding Your Genetic Test Results

Our comprehensive genetic report provides clear, actionable information:

  • Positive Result: Indicates presence of CD2AP mutation; requires consultation with nephrologist and genetic counselor for management strategy
  • Negative Result: Suggests CD2AP mutation not detected; other causes of kidney disease should be investigated
  • Variant of Uncertain Significance: Requires additional family studies and periodic re-evaluation as research advances
  • Carrier Status: Important for family planning and understanding inheritance patterns

Test Details and Pricing

Test Component Details
Test Name CD2AP Gene Focal Segmental Glomerulosclerosis Type 3 NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Preparation Requirements

To ensure optimal testing accuracy, we recommend:

  • Complete clinical history documentation of the patient
  • Genetic counseling session to create detailed family pedigree
  • Discussion of testing implications with healthcare provider
  • Understanding of potential psychological impact of results
  • Informed consent process for genetic testing

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic counselors and nephrology specialists ensures comprehensive care regardless of your location.

Take Control of Your Kidney Health Today

Don’t let uncertainty about inherited kidney conditions affect your health and family planning decisions. Our CD2AP genetic test provides the clarity needed for informed medical choices and proactive health management. With our special discounted price of $500 USD (regularly $700), this essential genetic screening is more accessible than ever.

Ready to schedule your genetic test? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Our team is available to answer your questions and guide you through the testing process with compassion and expertise.

Early detection through genetic testing can significantly impact treatment outcomes and quality of life. Take the first step toward understanding your genetic kidney health profile today.